By Michele Maatouk
Date: Tuesday 12 Nov 2024
(Sharecast News) - Schrödinger surged on Tuesday after it announced a $2.5bn research collaboration and license agreement with Novartis to advance multiple development candidates into the Swiss pharma firm's portfolio for further development.
No recent information was found.
Currency | US Dollars |
Share Price | $ 20.32 |
Change Today | $ 0.74 |
% Change | 3.75 % |
52 Week High | $26.89 |
52 Week Low | $16.98 |
Volume | 1,896,993 |
RiskGrade | 294 |
Time | Volume / Share Price |
16:00 | 168,110 @ $20.32 |
15:59 | 100 @ $20.32 |
15:59 | 100 @ $20.32 |
15:59 | 102 @ $20.30 |
15:59 | 208 @ $20.32 |
You are here: research